CanSino Biologics Inc.
CanSino Biologics Inc. (HKSE: 6185) is trading at HK$31.74, about ₹388 at today's HKD/INR rate, as of 27 Sep 2026, 11:41 PM ET, up 4.48% today. Indian residents can buy CanSino Biologics from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
HK$30.58
Today's high
HK$33.10
52 week low
HK$19.22
52 week high
HK$53.45
6185 opened at HK$31.06, closed previously at HK$30.38, and has traded between HK$19.22 and HK$53.45 over the past 52 weeks.
About
CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People’s Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N. meningitides. It develops DTcP vaccine for infants and DTcP Booster vaccine, which are in Phase I clinical trial for addressing the weaker protection preventing pertussis after primary vaccination. In addition, it develops Tdcp Adolescent and Adult vaccine for treating pertussis; PBPV, a serotype-independent protein-based pneumococcal vaccine that is in Phase I clinical trial; PCV13i, a pneumococcal conjugate vaccine, which is in Phase I clinical trial; and TB Booster for the BCG-vaccinated population which is in Phase I clinical trial. Further, it is developing various preclinical stage products, including DTcP-Hib Combo vaccine; CS-2023 to treat meningitis; CS-2028 for treating multivalent conjugate vaccine; CS-2032 for hingles; CS-2036 to treat polio; CS-2047 for treating tetanus; and CS-2201 DTcP for combination vaccine. The company was incorporated in 2009 and is headquartered in Tianjin, the People’s Republic of China.
Key statistics
Avg. volume
3.58M
Market cap
HK$11.11B
P/E Ratio
431.06
Price-to-sales ratio
12.49
Enterprise value
CN¥15.24B
Free cash flow yield
-0.81%
Debt-to-equity ratio
0.20
Return on equity
0.82%
ROIC
0.18%
Beta
1.24
Dividend yield
0.00%
Last dividend
HK$0.00
Financial overview
Revenue
CN¥1.03B
Earnings per share
CN¥0.11
Free cash flow
-CN¥152.83M
Net profit margin
3.29%
Gross margin
72.43%
EBITDA
CN¥60.98M
Revenue growth
21.93%
Similar securities
This is not an investment recommendation
How to buy CanSino Biologics from India
Indian residents can buy CanSino Biologics shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to HKD.
Search for CanSino Biologics and place an order
Find CanSino Biologics by name or by its ticker, 6185, and choose an order type. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. CanSino Biologics trades 7:00 am – 1:30 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your CanSino Biologics position in HKD and INR. CanSino Biologics pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in CanSino Biologics from India
Trading and taxes when buying CanSino Biologics from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm HKT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneCanSino Biologics does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy CanSino Biologics stock?
Yes. CanSino Biologics (6185) has been listed on the Hong Kong Stock Exchange since 2019, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to HKD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one CanSino Biologics share cost in rupees?
One CanSino Biologics share is HK$31.74 — about ₹388 at an HKD/INR rate of 12.24 on 27 Sep 2026. Both the CanSino Biologics price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying CanSino Biologics from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of CanSino Biologics?
Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
How are gains on CanSino Biologics shares taxed in India?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the HKD/INR rate on the purchase and the sale date, so the rupee move counts alongside the CanSino Biologics price. Paasa issues a capital-gains statement for your return.
Does CanSino Biologics pay a dividend?
No. CanSino Biologics does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade CanSino Biologics from India?
The Hong Kong Stock Exchange trades 7:00 am – 1:30 pm IST in Indian time. It also halts for lunch, 9:30 am – 10:30 am IST. Orders can only execute during that window.
Is CanSino Biologics a Hong Kong SAR China company, and does that change how it is taxed?
CanSino Biologics trades on the Hong Kong Stock Exchange in HKD, but the company is domiciled in China. CanSino Biologics trades as an ordinary share listed directly in Hong Kong, not a depositary receipt. Your India-side capital-gains treatment is the same either way.
Do I have to declare CanSino Biologics shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your CanSino Biologics holding, its cost and its closing value.
How do I sell CanSino Biologics and bring the money back to India?
You sell during market hours (7:00 am – 1:30 pm IST) and the proceeds settle in HKD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.